{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:28:46Z","timestamp":1790634526671,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.revmed.2017.09.002","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T12:45:15Z","timestamp":1509108315000},"page":"287-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Cryopyrinopathies"],"prefix":"10.1016","volume":"39","author":[{"given":"P.","family":"Quartier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2017.09.002_bib0005","first-page":"365","article-title":"A case of extreme enlargement of the articular epiphyses of the larger joints, from rickets","volume":"III","author":"Brayne","year":"1835","journal-title":"Trans Prov Med Surg Assoc"},{"key":"10.1016\/j.revmed.2017.09.002_bib0010","first-page":"82","article-title":"Severe osteoarthritis in a boy \u2013\u00a0remarkable distortion of joints, & c. (with portrait)","volume":"V","author":"Hutchinson","year":"1893","journal-title":"Arch Surg"},{"key":"10.1016\/j.revmed.2017.09.002_bib0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/brain\/73.3.281","article-title":"Adult toxoplasmosis in one family","volume":"73","author":"Campbell","year":"1950","journal-title":"Brain J Neurol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0020","first-page":"103","article-title":"A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy","volume":"19","author":"Prieur","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0025","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-3476(81)80961-4","article-title":"Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation","volume":"99","author":"Prieur","year":"1981","journal-title":"J Pediatr"},{"key":"10.1016\/j.revmed.2017.09.002_bib0030","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","article-title":"Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition","volume":"355","author":"Goldbach-Mansky","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2017.09.002_bib0035","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.25057","article-title":"Long-term efficacy of the interleukin-1\u00a0receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease\/chronic infantile neurologic, cutaneous, articular syndrome","volume":"62","author":"Neven","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.09.002_bib0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13023-017-0589-1","article-title":"Neurological outcome of patients with cryopyrin-associated periodic syndrome (CAPS)","volume":"12","author":"Mamoudjy","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.revmed.2017.09.002_bib0045","first-page":"235","article-title":"Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome","volume":"31","author":"Muckle","year":"1962","journal-title":"Q J Med"},{"key":"10.1016\/j.revmed.2017.09.002_bib0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.iac.2004.01.001","article-title":"The spectrum of acquired and familial cold-induced urticaria\/urticaria-like syndromes","volume":"24","author":"Wanderer","year":"2004","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.revmed.2017.09.002_bib0055","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1212\/WNL.0000000000002300","article-title":"Chorea in a patient with cryopyrin-associated periodic syndrome","volume":"86","author":"Schwarzbach","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.revmed.2017.09.002_bib0060","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3109\/0886022X.2013.790300","article-title":"Nephrotic syndrome and AA amyloidosis revealing adult-onset cryopyrin-associated periodic syndrome","volume":"35","author":"Enr\u00edquez","year":"2013","journal-title":"Ren Fail"},{"key":"10.1016\/j.revmed.2017.09.002_bib0065","article-title":"Novel evidences of atypical manifestations in cryopyrin-associated periodic syndromes","author":"Bujan-Rivas","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/jpc.13270","article-title":"Cryopyrin-associated periodic syndrome in Australian children and adults: epidemiological, clinical and treatment characteristics","volume":"52","author":"Mehr","year":"2016","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.revmed.2017.09.002_bib0075","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10067-016-3523-3","article-title":"Muckle-Wells syndrome in Chinese patients: a single center case series","volume":"36","author":"Wu","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0080","first-page":"659","article-title":"Cryopyrin-associated periodic syndrome","volume":"16","author":"Giat","year":"2014","journal-title":"Isr Med Assoc J IMAJ"},{"key":"10.1016\/j.revmed.2017.09.002_bib0085","first-page":"S115","article-title":"Genetic and clinical features of cryopyrin-associated periodic syndromes in Turkish children","volume":"34","author":"Eroglu","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0090","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1086\/302589","article-title":"Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44","volume":"65","author":"Cuisset","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.revmed.2017.09.002_bib0095","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1086\/302874","article-title":"Identification of a locus on chromosome 1q44\u00a0for familial cold urticaria","volume":"66","author":"Hoffman","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.revmed.2017.09.002_bib0100","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2017.09.002_bib0105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/341357","article-title":"Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes","volume":"71","author":"Feldmann","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.revmed.2017.09.002_bib0110","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1002\/art.10688","article-title":"De novo CIAS1\u00a0mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases","volume":"46","author":"Aksentijevich","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.09.002_bib0115","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood-2003-07-2531","article-title":"Molecular basis of the spectral expression of CIAS1\u00a0mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA\/NOMID, MWS, and FCU","volume":"103","author":"Neven","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2017.09.002_bib0120","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","article-title":"Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136\u00a0patients from the Eurofever Registry","volume":"74","author":"Levy","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.09.002_bib0125","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1182\/blood-2007-06-094201","article-title":"Disease-associated CIAS1\u00a0mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients","volume":"111","author":"Saito","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2017.09.002_bib0130","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/annrheumdis-2013-204361","article-title":"Somatic NLRP3\u00a0mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes","volume":"74","author":"Nakagawa","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.09.002_bib0135","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1002\/art.39190","article-title":"Brief report: cryopyrin-associated periodic syndrome caused by a myeloid-restricted somatic NLRP3\u00a0mutation","volume":"67","author":"Zhou","year":"2015","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.revmed.2017.09.002_bib0140","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/art.39770","article-title":"Brief report: late-onset cryopyrin-associated periodic syndrome due to myeloid-restricted somatic NLRP3\u00a0mosaicism","volume":"68","author":"Mensa-Vilaro","year":"2016","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.revmed.2017.09.002_bib0145","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1586\/1744666X.2015.1047765","article-title":"Diagnosis of cryopyrin-associated periodic syndrome: challenges, recommendations and emerging concepts","volume":"11","author":"Sarrabay","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0150","doi-asserted-by":"crossref","DOI":"10.1002\/art.40208","article-title":"Clinical and molecular phenotypes of low-penetrance variants in NLRP3: diagnostic and therapeutic challenges","author":"Kuemmerle-Deschner","year":"2017","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"10.1016\/j.revmed.2017.09.002_bib0155","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar4171","article-title":"Clinical characteristics in subjects with NLRP3\u00a0V198M diagnosed at a single UK center and a review of the literature","volume":"15","author":"Rowczenio","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2017.09.002_bib0160","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.3899\/jrheum.150962","article-title":"Clinical characteristics of patients carrying the Q703K variant of the NLRP3\u00a0gene: a 10-year multicentric national study","volume":"43","author":"Naselli","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0165","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4103\/0366-6999.200537","article-title":"A novel mutation in the pyrin domain of the NOD-like receptor family pyrin domain containing protein 3\u00a0in Muckle-Wells syndrome","volume":"130","author":"Hu","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.revmed.2017.09.002_bib0170","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/ni.3538","article-title":"NLRP3\u00a0inflammasome inhibition is disrupted in a group of auto-inflammatory disease CAPS mutations","volume":"17","author":"Mortimer","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0175","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1073\/pnas.1424741112","article-title":"Cell stress increases ATP release in NLRP3\u00a0inflammasome-mediated autoinflammatory diseases, resulting in cytokine imbalance","volume":"112","author":"Carta","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.revmed.2017.09.002_bib0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1189\/jlb.3MR0415-159R","article-title":"Redox stress unbalances the inflammatory cytokine network: role in autoinflammatory patients and healthy subjects","volume":"99","author":"Lavieri","year":"2016","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0185","doi-asserted-by":"crossref","first-page":"aad1210","DOI":"10.1126\/science.aad1210","article-title":"T helper 1\u00a0immunity requires complement-driven NLRP3\u00a0inflammasome activity in CD4+ T cells","volume":"352","author":"Arbore","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.revmed.2017.09.002_bib0190","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000446615","article-title":"Induction of myeloid-derived suppressor cells in cryopyrin-associated periodic syndromes","volume":"8","author":"Ballbach","year":"2016","journal-title":"J Innate Immun"},{"key":"10.1016\/j.revmed.2017.09.002_bib0195","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jaci.2016.05.016","article-title":"DNA demethylation of inflammasome-associated genes is enhanced in patients with cryopyrin-associated periodic syndromes","volume":"139","author":"Vento-Tormo","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0200","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/annrheumdis-2016-209686","article-title":"Diagnostic criteria for cryopyrin-associated periodic syndrome (CAPS)","volume":"76","author":"Kuemmerle-Deschner","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.09.002_bib0205","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/ard.2010.132613","article-title":"A preliminary score for the assessment of disease activity in hereditary recurrent fevers: results from the AIDAI (Auto-Inflammatory Diseases Activity Index) Consensus Conference","volume":"70","author":"Piram","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.09.002_bib0210","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1056\/NEJM200306193482523","article-title":"Interleukin-1-receptor antagonist in the Muckle-Wells syndrome","volume":"348","author":"Hawkins","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2017.09.002_bib0215","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1\u00a0Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.09.002_bib0220","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2017.09.002_bib0225","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/art.23620","article-title":"A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1\u00a0inhibitor rilonacept (interleukin-1\u00a0Trap) in patients with familial cold autoinflammatory syndrome","volume":"58","author":"Goldbach-Mansky","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.09.002_bib0230","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/art.30149","article-title":"Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome","volume":"63","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2017.09.002_bib0235","doi-asserted-by":"crossref","first-page":"R202","DOI":"10.1186\/ar3535","article-title":"Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study","volume":"13","author":"Kon\u00e9-Paut","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2017.09.002_bib0240","first-page":"302","article-title":"Safety and efficacy of canakinumab in Japanese patients with phenotypes of cryopyrin-associated periodic syndrome as established in the first open-label, phase-3\u00a0pivotal study (24-week results)","volume":"31","author":"Imagawa","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0245","article-title":"Long-term safety and efficacy of canakinumab in cryopyrin-associated periodic syndrome: results from an open-label, phase III pivotal study in Japanese patients","author":"Yokota","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0250","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/rheumatology\/kev416","article-title":"Real-life effectiveness of canakinumab in cryopyrin-associated periodic syndrome","volume":"55","author":"Kuemmerle-Deschner","year":"2016","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.revmed.2017.09.002_bib0255","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1136\/ard.2011.152728","article-title":"Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes","volume":"70","author":"Kuemmerle-Deschner","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2017.09.002_bib0260","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1546-0096-12-52","article-title":"Neonatal treatment of CINCA syndrome","volume":"12","author":"Paccaud","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.revmed.2017.09.002_bib0265","doi-asserted-by":"crossref","first-page":"e1468","DOI":"10.1542\/peds.2013-3185","article-title":"Successful management of cryopyrin-associated periodic syndrome with canakinumab in infancy","volume":"134","author":"Kanariou","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.revmed.2017.09.002_bib0270","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar4184","article-title":"The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age","volume":"15","author":"Caorsi","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2017.09.002_bib0275","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/2050-6511-14-40","article-title":"Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes","volume":"14","author":"Urien","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0280","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10067-013-2481-2","article-title":"Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1\u03b2 monoclonal antibody canakinumab","volume":"34","author":"Scarpioni","year":"2015","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0285","unstructured":"Georgin-Lavialle S, et al. AA Amyloidosis complicating cryopyrin-associated periodic syndrome: a study on 86\u00a0cases including 27\u00a0french patients and 59\u00a0from literature. Manuscr Prep n.d. [en cours de soumission]."},{"key":"10.1016\/j.revmed.2017.09.002_bib0290","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12969-015-0041-9","article-title":"Early detection of sensorineural hearing loss in Muckle-Wells-syndrome","volume":"13","author":"Kuemmerle-Deschner","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"key":"10.1016\/j.revmed.2017.09.002_bib0295","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00296-010-1787-5","article-title":"Long-term response after 6-year treatment with anakinra and onset of focal bone erosion in neonatal-onset multisystem inflammatory disease (NOMID\/CINCA)","volume":"31","author":"Rigante","year":"2011","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.revmed.2017.09.002_bib0300","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/acr.23083","article-title":"Real-world experience and impact of canakinumab in cryopyrin-associated periodic syndrome: results from a french observational study","volume":"69","author":"Kone-Paut","year":"2017","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.revmed.2017.09.002_bib0305","first-page":"404","article-title":"Successful renal transplantation in Muckle-Wells syndrome treated with anti-IL-1\u03b2-monoclonal antibody","volume":"4","author":"Kortus-G\u00f6tze","year":"2011","journal-title":"NDT Plus"},{"key":"10.1016\/j.revmed.2017.09.002_bib0310","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kex185","article-title":"Safety of vaccinations in patients with cryopyrin-associated periodic syndromes: a prospective registry based study","author":"Jaeger","year":"2017","journal-title":"Rheumatol Oxf Engl"},{"key":"10.1016\/j.revmed.2017.09.002_bib0315","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3\u00a0inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.revmed.2017.09.002_bib0320","first-page":"22","article-title":"Synthesis and biological evaluation of novel benzimidazole derivatives and analogs targeting the NLRP3\u00a0inflammasome","author":"Pan","year":"2017","journal-title":"Mol Basel Switz"},{"key":"10.1016\/j.revmed.2017.09.002_bib0325","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1210\/jc.2012-1801","article-title":"Serum amyloid A: expression throughout human ovarian folliculogenesis and levels in follicular fluid of women undergoing controlled ovarian stimulation","volume":"98","author":"Urieli-Shoval","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2017.09.002_bib0330","doi-asserted-by":"crossref","first-page":"067","DOI":"10.1186\/1546-0096-13-S1-O67","article-title":"International experience of pregnancy outcomes in auto-inflammatory syndromes treated with Interleukin-1\u00a0inhibitors","volume":"13","author":"Youngstein","year":"2015","journal-title":"Pediatr Rheum"},{"key":"10.1016\/j.revmed.2017.09.002_bib0335","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1073\/pnas.0708616105","article-title":"Mutations in NALP12\u00a0cause hereditary periodic fever syndromes","volume":"105","author":"J\u00e9ru","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.revmed.2017.09.002_bib0340","doi-asserted-by":"crossref","first-page":"A90","DOI":"10.1016\/j.revmed.2016.10.053","article-title":"Les fi\u00e8vres h\u00e9r\u00e9ditaires p\u00e9riodiques associ\u00e9es \u00e0 des mutations de NLRP12\u00a0: revue syst\u00e9matique de la litt\u00e9rature","volume":"37","author":"Rodrigues","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.09.002_bib0345","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/ng.3089","article-title":"An activating NLRC4\u00a0inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome","volume":"46","author":"Canna","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2017.09.002_bib0350","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/ng.3066","article-title":"Mutation of NLRC4\u00a0causes a syndrome of enterocolitis and autoinflammation","volume":"46","author":"Romberg","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.revmed.2017.09.002_bib0355","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1084\/jem.20141091","article-title":"An inherited mutation in NLRC4\u00a0causes autoinflammation in human and mice","volume":"211","author":"Kitamura","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.revmed.2017.09.002_bib0360","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bjd.14757","article-title":"Erythematous nodes, urticarial rash and arthralgias in a large pedigree with NLRC4-related autoinflammatory disease, expansion of the phenotype","volume":"176","author":"Volker-Touw","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0365","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18\u00a0inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0370","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1102140","article-title":"Cold urticaria, immunodeficiency, and autoimmunity related to PLCG2\u00a0deletions","volume":"366","author":"Ombrello","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2017.09.002_bib0375","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jamadermatol.2014.5641","article-title":"Distinct cutaneous manifestations and cold-induced leukocyte activation associated with PLCG2\u00a0mutations","volume":"151","author":"Aderibigbe","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.revmed.2017.09.002_bib0380","article-title":"[Mevalonate kinase deficiency in 2016]","author":"Galeotti","year":"2016","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2017.09.002_bib0385","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.arcped.2010.04.002","article-title":"[Guidelines for diagnosis and treatment of oligoarticular and polyarticular juvenile idiopathic arthritis]","volume":"17","author":"Bader-Meunier","year":"2010","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.revmed.2017.09.002_bib0390","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11926-017-0673-5","article-title":"Schnitzler syndrome: a review","volume":"19","author":"Gusdorf","year":"2017","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.revmed.2017.09.002_bib0395","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jaci.2014.07.050","article-title":"Myeloid lineage-restricted somatic mosaicism of NLRP3\u00a0mutations in patients with variant Schnitzler syndrome","volume":"135","author":"de Koning","year":"2015","journal-title":"J Allergy Clin Immunol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866317306355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866317306355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:39:01Z","timestamp":1759336741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866317306355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":79,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0248866317306355"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2017.09.002","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cryopyrinopathies","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2017.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}